Brief Report: Hispanic Patients’ Trajectory of Cancer Symptom Burden, Depression, Anxiety, and Quality of Life
Eida Castro, Normarie Torres‐Blasco, Milagros C. Rosal, Julio Jiménez, Wallesca P. Castro-Rodríguez, Marilis E. González-Lorenzo, Héctor Vélez-Cortés, Alia Toro-Bahamonde, Rosario Costas-Muñíz, Guillermo N. Armaiz-Peña, Heather Jim
Abstract
Anxiety and depression symptoms are known to increase cancer symptom burden, yet little is known about the longitudinal integrations of these among Hispanic/Latinx patients. The goal of this study was to explore the trajectory and longitudinal interactions among anxiety and depression, cancer symptom burden, and health-related quality of life in Hispanic/Latinx cancer patients undergoing chemotherapy. METHODS: Baseline behavioral assessments were performed before starting chemotherapy. Follow-up behavioral assessments were performed at 3, 6, and 9 months after starting chemotherapy. Descriptive statistics, chi-square tests, Fisher's exact tests, and Mann-Whitney tests explored associations among outcome variables. Adjusted multilevel mixed-effects linear regression models were also used to evaluate the association between HADS scores, follow-up visits, FACT-G scale, MDASI scale, and sociodemographic variables. RESULTS: Increased cancer symptom burden was significantly related to changes in anxiety symptoms' scores (adjusted β^ = 0.11 [95% CI: 0.02, 0.19]. Increased quality of life was significantly associated with decreased depression and anxiety symptoms (adjusted β^ = -0.33; 95% CI: -0.47, -0.18, and 0.38 adjusted β^= -0.38; 95% CI: -0.55, -0.20, respectively). CONCLUSIONS: Findings highlight the need to conduct periodic mental health screenings among cancer patients initiating cancer treatment.